Dr. Fatma Dogan is a Research Fellow at Massachusetts General Hospital and Harvard Medical School. She earned a Master`s degree in Medical Biology and Genetics at Ege University, Turkey, and a PhD in Molecular Genetics at Keele University, England. Dr. Dogan is a trained geneticist whose research interests currently focus on autoimmune diseases.
Dr. Dogan’s current research focuses on developing new therapies for type 1 diabetes to enhance immunoprotection and support of transplanted allogeneic islets without systemic immune suppression to cure diabetes and targeted delivery of therapeutic cargo to the pancreatic islets for type 1 diabetes prevention and treatment.
Dr. Dogan received a Fellowship from the Turkish Ministry of Education to conduct her PhD in Genetics at Keele University in England, working on epigenetic regulation of telomerase enzyme before joining VIC.
- Research Fellow, Massachusetts General Hospital at Harvard Medical School, USA, 2022 Vaccine & Immunotherapy Center
- Doctor of Philosophy – PhD Molecular Genetics Keele University, England, 2018 – 2022 Institute for Science and Technology in Medicine / School of Pharmacy and Bioengineering
- Master of Science – MSc Human/Medical Genetics Ege University, Turkey, 2016 – 2018 Medical Biology and Genetics Department